Ex-Loretto hospital CFO hit with new charges alleging massive $290 million COVID testing fraud scheme
A former top executive of Loretto Hospital on Chicago's West Side has been charged in a massive $290 million fraud scheme that allegedly used stolen patient data to bill nearly a billion dollars worth of bogus COVID-19 tests for purportedly uninsured patients at the height of the pandemic.
The 48-page indictment unsealed in U.S. District Court on Tuesday marked the latest — and largest — fraud scheme involving the small West Side safety-net hospital that became a lighting rod of controversy during the coronavirus pandemic for administering vaccinations to connected insiders and paying millions in contracts to companies with close ties to facility administrators.
Anosh Ahmed, who was previously indicted in a related scheme to embezzle $15 million from Loretto itself, was charged in the new 24-count indictment with wire fraud, illegal kickbacks and other financial crimes.
Also charged were Mohamed Sirajudeen, 53, an Ahmed associate who operated a clinic called Chicago Polyclinic LLC, as well as Mahmood Sami Khan, 36, and Suhaib Ahmad Chaudhry, 34, both former employees of Anosh Inc., a Houston-area company Ahmed formed after leaving Loretto in 2021.
Ahmed, 41, fled to Dubai before he was first charged last year and has not returned, court records show. Over the past year, he's been using a public relations firm to produce news releases calling himself a 'billionaire agripreneur' dedicated to philanthropic causes, including donating millions of pounds of food to the needy in Lebanon.
His lawyer, Dan Webb, could not immediately be reached.
Chaudhry and Khan were arrested in the Houston area Tuesday and were expected to appear in court there on Wednesday, court records show. Sirajudeen has arranged to surrender through his attorney. It was not clear if any of the three defendants had hired attorneys.
According to the indictment, from April 2021 to June 2022, Ahmed and his co-conspirators used laboratories they opened in Illinois and Texas to submit false claims to the Health Resources and Services Administration for COVID testing of specimens 'purportedly collected from uninsured individuals, knowing that such testing had not occurred.'
In all, the false claims sought reimbursement for nearly $895 million, of which more than $293 million was actually paid, the indictment stated.
To further the scheme, after Ahmed left Loretto Hospital in April 2021, he had a hospital executive identified as Individual F to obtain a spreadsheet containing personal identifiers — including names, dates of birth, gender and addresses — collected from
more than 150,000 Loretto patient visits between July 2014 and June 2020, the indictment alleged.
Similar personal information was collected from patients who ordered COVID-19 antigen at-home test kits from an internet site run by Khan, as well as individuals who provided it 'for the purpose of receiving further information about COVID-19,' the indictment stated.
The indictment alleged Ahmed used a variety of methods to try to conceal the scheme, including by having Individual F create a new email address with Loretto's domain name to 'create the false appearance that Ahmed was working on behalf of (Loretto)' and that the hospital was reporting test results to patients, the indictment alleged.
Ahmed also created a number of false and backdated invoices to minimize his involvement with the various labs, communicated in encrypted messaging apps and ordered co-schemers to replace phones and destroy communications and other documents relating to the scheme, the indictment stated.
The indictment sought forfeiture in more than $100 million in cash and securities in various accounts controlled by Ahmed, as well as seizure of four luxury properties in Texas, and vehicles including two Rolls-Royces, a Lamborghini Huracan and a Mercedes Benz.
The indictment is the latest in a federal investigation initiated after Loretto came under fire for improperly doling out COVID-19 vaccinations soon after the shots became available. In 2021, following reporting by Block Club Chicago and WBEZ, Loretto admitted it had improperly vaccinated workers at Trump Tower in downtown Chicago and had also improperly given shots to Cook County judges at a time when the vaccines were still scarce.
Ahmed resigned from his position as chief financial officer in 2021 after the hospital's board voted to terminate him.
Last year, Ahmed was charged in a separate embezzlement case along with former Loretto CEO George Miller; Heather Bergdahl, a friend of Ahmed's from Houston whom he hired in 2020 to serve as Loretto's chief transformation officer; and Sameer Suhail, 47, of Chicago, a doctor and medical supply company owner accused of serving as a front for millions of dollars in bogus payments by Loretto for invoices that were never fulfilled.
Miller, who left the hospital amid the fallout in 2022, is cooperating and is expected to plead guilty.
Suhail is also believed to be living in Dubai, where he traveled before his indictment. Bergdahl, meanwhile, was arrested after boarding a private jet in Houston that was bound for Dubai. She has pleaded not guilty and is awaiting trial.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
CleanJoule's SpaceSAF Successfully Fuels a Rotating Detonation Rocket Engine
The recent ground test illustrates the viability of high-performance alternative fuels for space missions PARIS, June 18, 2025--(BUSINESS WIRE)--In a first-of-its-kind test, CleanJoule's high-performance alternative rocket fuel, SpaceSAF, was successfully used to power a Rotating Detonation Rocket Engine (RDRE) developed by Venus Aerospace, marking a major validation of next-generation fuel compatibility with cutting-edge propulsion systems. The ground test was conducted at Venus's Houston-based test site and represents a significant step forward in expanding the operational flexibility of RDRE technology across dual use missions. "Without affordable, domestically-produced alternative fuels, the financial and environmental costs of space missions become unsustainable," said Mukund Karanjikar, CEO and founder, CleanJoule. "The successful detonation of an RDRE utilizing SpaceSAF proves that alternative fuels can deliver for both performance and emissions needs in commercial and defense applications." SpaceSAF is a drop-in replacement for liquid (RP-1 & RP-2) rocket fuels that improves mission performance including increasing payload and distance. From the same base material used to produce SpaceSAF, CleanJoule also produces a sustainable solid rocket fuel (SSRF) for use as a superior performance, drop-in replacement for existing solid rocket motors. This milestone comes at a critical time with an ecosystem emerging that is focused on expanding access to space across satellite deployment, exploration, and defense systems. As more frequent launches drive up related CO2 emissions, the need for performant alternatives to conventional rocket fuels is urgent. "This test helps advance an important conversation in aerospace: how to pair next-gen propulsion with alternative fuels that don't compromise on performance," said Nick Cardwell, VP of Product and Advanced Concepts, Venus Aerospace. "CleanJoule's work on high-performance, low-emissions fuels contributes meaningfully to an evolving space and defense ecosystem, and we're pleased to see their product perform under real operational conditions." About CleanJoule CleanJoule Inc., headquartered in Salt Lake City, Utah, is an advanced fuels company that enhances performance across commercial and defense aerospace. CleanJoule's breakthrough pathway produces the only full performance, 100 percent drop-in advanced fuel that can be used for commercial, military, and space applications. CleanJoule's focus is on distributed manufacturing of advanced aviation fuels using readily available domestic biomass feedstocks, further ensuring supply chain resilience. CleanJoule's manufacturing process has superior efficiency while increasing energy density and reducing carbon emissions, soot, and contrail formation. Backed by Indigo Partners, Cleanhill Partners, GenZero, Frontier Airlines, Wizz Airlines, and Volaris, CleanJoule is on a mission to create superior aerospace and defense fuels that enable domestic supply chain resiliency. For more information, visit View source version on Contacts Media Kate Gundrycleanjoule@ 617-797-5174 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
CleanJoule's SpaceSAF Successfully Fuels a Rotating Detonation Rocket Engine
PARIS--(BUSINESS WIRE)--In a first-of-its-kind test, CleanJoule's high-performance alternative rocket fuel, SpaceSAF, was successfully used to power a Rotating Detonation Rocket Engine (RDRE) developed by Venus Aerospace, marking a major validation of next-generation fuel compatibility with cutting-edge propulsion systems. The ground test was conducted at Venus's Houston-based test site and represents a significant step forward in expanding the operational flexibility of RDRE technology across dual use missions. The successful detonation of an RDRE utilizing SpaceSAF proves that alternative fuels can deliver on both performance and emissions needs in commercial and defense applications. Share 'Without affordable, domestically-produced alternative fuels, the financial and environmental costs of space missions become unsustainable,' said Mukund Karanjikar, CEO and founder, CleanJoule. "The successful detonation of an RDRE utilizing SpaceSAF proves that alternative fuels can deliver for both performance and emissions needs in commercial and defense applications.' SpaceSAF is a drop-in replacement for liquid (RP-1 & RP-2) rocket fuels that improves mission performance including increasing payload and distance. From the same base material used to produce SpaceSAF, CleanJoule also produces a sustainable solid rocket fuel (SSRF) for use as a superior performance, drop-in replacement for existing solid rocket motors. This milestone comes at a critical time with an ecosystem emerging that is focused on expanding access to space across satellite deployment, exploration, and defense systems. As more frequent launches drive up related CO2 emissions, the need for performant alternatives to conventional rocket fuels is urgent. 'This test helps advance an important conversation in aerospace: how to pair next-gen propulsion with alternative fuels that don't compromise on performance,' said Nick Cardwell, VP of Product and Advanced Concepts, Venus Aerospace. 'CleanJoule's work on high-performance, low-emissions fuels contributes meaningfully to an evolving space and defense ecosystem, and we're pleased to see their product perform under real operational conditions.' About CleanJoule CleanJoule Inc., headquartered in Salt Lake City, Utah, is an advanced fuels company that enhances performance across commercial and defense aerospace. CleanJoule's breakthrough pathway produces the only full performance, 100 percent drop-in advanced fuel that can be used for commercial, military, and space applications. CleanJoule's focus is on distributed manufacturing of advanced aviation fuels using readily available domestic biomass feedstocks, further ensuring supply chain resilience. CleanJoule's manufacturing process has superior efficiency while increasing energy density and reducing carbon emissions, soot, and contrail formation. Backed by Indigo Partners, Cleanhill Partners, GenZero, Frontier Airlines, Wizz Airlines, and Volaris, CleanJoule is on a mission to create superior aerospace and defense fuels that enable domestic supply chain resiliency. For more information, visit
CBS News
3 hours ago
- CBS News
Former CEO of Chicago's Loretto Hospital accused of nearly $300 million via COVID testing scheme
A former executive at Chicago's Loretto Hospital is charged with stealing $290 million through a COVID testing scheme. Prosecutors said Anosh Ahmed, the former chief executive officer and chief financial officer of the West Side hospital, was among a group that submitted nearly $900 million of false claims for COVID testing — and collected payments totaling $290 million. In November 2024, Ahmed was also among three people indicted on charges of scheming to embezzle more than $15 million from Loretto Hospital. A federal grand jury has been investigating Loretto's COVID-19 vaccination program, after the hospital admitted to giving hundreds of COVID shots to people who were not yet eligible to get them. Ahmed resigned from Loretto in March 2021, after the hospital had arranged COVID-19 vaccinations for hundreds of well-connected people who were not yet eligible for the shots at a time when vaccinations were in short supply. Then-CEO George Miller was suspended for two weeks shortly after Ahmed resigned, after he admitted to arranging for vaccines for people who weren't eligible to get them, including workers at Trump Tower, and members of an Oak Forest church. Miller later left Loretto in April 2022. The Chicago Department of Public Health cut off Loretto's supply of COVID-9 vaccines in March 2021, after learning about the scandal. The city later restored vaccinations at the hospital about a month later, after stepping in to run a new clinic to make sure shots went to those who were eligible. contributed to this report.
